Europe Precision Diagnostics Market Size, Share & Trends Analysis Report By End-use, By Type, By Application (Oncology, Respiratory Diseases, CNS Disorders, Immunology, Skin Diseases, Genetic Diseases, and Others), By Country and Growth Forecast, 2024 - 2031
The Europe Precision Diagnostics Market would witness market growth of 17.6% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Precision Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $3,500.1 million by 2031. The UK market is exhibiting a CAGR of 16.6% during (2024 - 2031). Additionally, The France market would experience a CAGR of 18.9% during (2024 - 2031).
Precision diagnostics encompass a wide range of applications across various fields of medicine, leveraging advanced technologies to enhance diagnostic accuracy, personalize treatment strategies, and improve patient outcomes.
Moreover, precision diagnostics play a crucial role in oncology, where personalized treatment approaches are increasingly based on tumors' genetic and molecular characteristics. Identifying mutations (e.g., BRCA1/2 in breast cancer) influencing cancer risk and treatment response.
Europe faces a high burden of respiratory diseases such as chronic obstructive pulmonary disease and respiratory infections due to factors like air pollution, an aging population, and lifestyle habits. As per Eurostat, in 2020, there were 3,47,867 deaths in the EU resulting from diseases of the respiratory system, equivalent to 6.7 % of all deaths among residents. In 2020, the proportion of deaths from respiratory diseases in Malta, Denmark, and Ireland was considerably higher than the EU average, at 10.5 %, 10.4 %, and 10.0 %, respectively.
Based on End-use, the market is segmented into Clinical Laboratories, Hospitals, and Others. Based on Type, the market is segmented into Genetic Tests, Esoteric Tests, Direct to Consumer Tests, and Others. Based on Application, the market is segmented into Oncology, Respiratory Diseases, CNS Disorders, Immunology, Skin Diseases, Genetic Diseases, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers AG (Siemens AG)
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- BioMerieux S.A.
- Becton, Dickinson and Company
- Qiagen N.V
- Hologic, Inc.
By End-use
- Clinical Laboratories
- Hospitals
- Others
- Genetic Tests
- Esoteric Tests
- Direct to Consumer Tests
- Others
- Oncology
- Respiratory Diseases
- CNS Disorders
- Immunology
- Skin Diseases
- Genetic Diseases
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Precision Diagnostics Market, by End-use
- 1.4.2 Europe Precision Diagnostics Market, by Type
- 1.4.3 Europe Precision Diagnostics Market, by Application
- 1.4.4 Europe Precision Diagnostics Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.3 Top Winning Strategies
- 4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2021, Jul – 2024, May) Leading Players
- 4.4 Porter Five Forces Analysis
- Chapter 5. Europe Precision Diagnostics Market by End-use
- 5.1 Europe Clinical Laboratories Market by Country
- 5.2 Europe Hospitals Market by Country
- 5.3 Europe Others Market by Country
- Chapter 6. Europe Precision Diagnostics Market by Type
- 6.1 Europe Genetic Tests Market by Country
- 6.2 Europe Esoteric Tests Market by Country
- 6.3 Europe Direct to Consumer Tests Market by Country
- 6.4 Europe Others Market by Country
- Chapter 7. Europe Precision Diagnostics Market by Application
- 7.1 Europe Oncology Market by Country
- 7.2 Europe Respiratory Diseases Market by Country
- 7.3 Europe CNS Disorders Market by Country
- 7.4 Europe Immunology Market by Country
- 7.5 Europe Skin Diseases Market by Country
- 7.6 Europe Genetic Diseases Market by Country
- 7.7 Europe Others Market by Country
- Chapter 8. Europe Precision Diagnostics Market by Country
- 8.1 Germany Precision Diagnostics Market
- 8.1.1 Germany Precision Diagnostics Market by End-use
- 8.1.2 Germany Precision Diagnostics Market by Type
- 8.1.3 Germany Precision Diagnostics Market by Application
- 8.2 UK Precision Diagnostics Market
- 8.2.1 UK Precision Diagnostics Market by End-use
- 8.2.2 UK Precision Diagnostics Market by Type
- 8.2.3 UK Precision Diagnostics Market by Application
- 8.3 France Precision Diagnostics Market
- 8.3.1 France Precision Diagnostics Market by End-use
- 8.3.2 France Precision Diagnostics Market by Type
- 8.3.3 France Precision Diagnostics Market by Application
- 8.4 Russia Precision Diagnostics Market
- 8.4.1 Russia Precision Diagnostics Market by End-use
- 8.4.2 Russia Precision Diagnostics Market by Type
- 8.4.3 Russia Precision Diagnostics Market by Application
- 8.5 Spain Precision Diagnostics Market
- 8.5.1 Spain Precision Diagnostics Market by End-use
- 8.5.2 Spain Precision Diagnostics Market by Type
- 8.5.3 Spain Precision Diagnostics Market by Application
- 8.6 Italy Precision Diagnostics Market
- 8.6.1 Italy Precision Diagnostics Market by End-use
- 8.6.2 Italy Precision Diagnostics Market by Type
- 8.6.3 Italy Precision Diagnostics Market by Application
- 8.7 Rest of Europe Precision Diagnostics Market
- 8.7.1 Rest of Europe Precision Diagnostics Market by End-use
- 8.7.2 Rest of Europe Precision Diagnostics Market by Type
- 8.7.3 Rest of Europe Precision Diagnostics Market by Application
- Chapter 9. Company Profiles
- 9.1 Abbott Laboratories
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Acquisition and Mergers:
- 9.1.6 SWOT Analysis
- 9.2 F. Hoffmann-La Roche Ltd.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.2.5.2 Product Launches and Product Expansions:
- 9.2.6 SWOT Analysis
- 9.3 Siemens Healthineers AG (Siemens AG)
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
- 9.3.5.1 Partnerships, Collaborations, and Agreements:
- 9.3.5.2 Product Launches and Product Expansions:
- 9.3.5.3 Acquisition and Mergers:
- 9.3.6 SWOT Analysis
- 9.4 Thermo Fisher Scientific, Inc.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.6 SWOT Analysis
- 9.5 Danaher Corporation
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
- 9.5.6 SWOT Analysis
- 9.6 Agilent Technologies, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Partnerships, Collaborations, and Agreements:
- 9.6.5.2 Product Launches and Product Expansions:
- 9.6.6 SWOT Analysis
- 9.7 BioMerieux S.A.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Partnerships, Collaborations, and Agreements:
- 9.7.5.2 Acquisition and Mergers:
- 9.7.6 SWOT Analysis
- 9.8 Becton, Dickinson, and Company
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expense
- 9.8.5 SWOT Analysis
- 9.9 Qiagen N.V.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expenses
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Partnerships, Collaborations, and Agreements:
- 9.9.5.2 Product Launches and Product Expansions:
- 9.9.6 SWOT Analysis
- 9.10. Hologic, Inc.
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook